Britannia Pharmaceuticals Limited is a British specialty pharmaceutical company specializing in products for diseases with orphan indications. The company has expertise in clinical trials, formulation, registration, marketing and sales. The Company is engaged in the development of products for the Parkinson's disease, opiate detoxification, erectile dysfunction, asthma, migrane, pain and infectious diseases.

Company was acquired by Stada Arzneimittel AG